“Long-term Clinical Efficacy and Safety of Thalidomide in Patients with Transfusion‑dependent β‑thalassemia Major” (2025) Indus Journal of Bioscience Research, 3(1), pp. 784–791. doi:10.70749/ijbr.v3i1.595.